Bristol Myers Squibb expands Nvidia partnership to build most powerful AI supercomputer for drug discovery

Bristol Myers Squibb announced an expanded partnership with Nvidia that will give it the most powerful and energy-efficient Nvidia infrastructure owned by a life-science company.

Nvidia says the planned system will be the most advanced supercomputer in the biopharma industry, measured by operations per second, and will support larger AI models and agents to accelerate drug discovery.

The initiative follows similar moves by Eli Lilly and Roche, which have also announced large Nvidia-based AI computing facilities, each using different metrics to claim superlative status.

Industry observers note that such high-performance computing resources could shorten development timelines, though the real impact will depend on how effectively the AI tools are integrated into research workflows.